BioPharma Dive March 4, 2024
Meg Richards, PhD, MBH Executive Director of Solutions, Panalgo With Mike Munsell, Director of Research, Panalgo

Sponsored content By Panalgo

In a rapidly evolving landscape where artificial intelligence (AI) and machine learning (ML) have become household terms, their impact on biopharmaceutical research and epidemiology is profound. I caught up with Mike Munsell, PhD, Director of Research at Panalgo, to discuss how these technologies are transforming the healthcare research landscape and their real-world applications in biopharmaceutical R&D. Classically trained epidemiologists know more about ML and AI than they think they do, and here’s why.

Q: We’re hearing more about AI, ML, and ChatGPT these days. Can you give me a definition of what each is and how they might overlap?

A: With AI, computers are essentially mimicking human decision-making. ML, a subdiscipline of AI, uses algorithms...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
AI in healthcare: What to expect in Trump's 2nd term
International collaboration to improve disease prevention with AI
Six AgeTech Offerings from HLTH 2024
System Design For The AI Era: The Path To AI-Native IoT
Nvidia advances robot learning and humanoid development with AI and simulation tools

Share This Article